BaroFold, Inc. CEO to Chair Panel Regarding Biologics and Drug Development Challenges: 'Novel Approaches to Protein Aggregation and Production' at the Biotechnology Industry Organization (BIO) International Conference  
5/7/2007 2:25:41 PM

BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc. announced today that Dr. Lyndal Hesterberg, President and CEO, will be chairing the panel discussion as part of the Biologics and Drug Development Challenges section: “Novel Approaches to Protein Aggregation and Production” at the Biotechnology Industry Organization’s International Convention.